Who better to fill us in on what the current vaccine development in the Chinese marketplace are than Dr Wang Hongguang, the Director-General for the China National Center for Biotechnology Development.
We will have the honour of welcoming Dr Wang at the 12th annual World Vaccine Congress in April, where he will be addressing the implications of the global vaccine market in China and the current capacity and gaps.
What has the recent and ongoing technology explosion and innovation changed in the Chinese vaccine market?
All this and much more will be discussed on April 11th 2012.
Get your questions ready!
Have a look at the Congress program here.
Ensure you join us at the event at the best possible ticket price by booking your place before the 27th January – register here.